**Question:** Ochsner-Sherren regimen is used for: September 2009, 2010

**Core Concept:** The Ochsner-Sherren regimen refers to a chemotherapy regimen used in the treatment of certain types of cancer. It is a combination therapy that includes various drugs targeting different pathways to maximize the effectiveness of treatment while minimizing side effects.

**Why the Correct Answer is Right:**
The correct answer is [Option C: Leukemia]. The Ochsner-Sherren regimen is specifically used in the treatment of acute lymphoblastic leukemia (ALL), a type of cancer that affects the white blood cells. This regimen consists of several drugs, including vincristine, prednisone, and asparaginase.

Vincristine is a microtubule-stabilizing agent that interferes with cell division and causes cancer cell death. Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation, which can help control the disease progression. Asparaginase, an enzyme, depletes asparagine, which is essential for cancer cell growth, leading to cancer cell death.

**Why Each Wrong Option is Incorrect:**

A. Option A (Myeloma): This regimen is primarily used in the treatment of multiple myeloma, not ALL. Multiple myeloma is a plasma cell disorder, while ALL affects lymphocytes.

B. Option B (Non-Hodgkin's Lymphoma): The Ochsner-Sherren regimen is not specifically used for non-Hodgkin's lymphoma (NHL). NHL involves B-cell proliferation, while ALL affects T-cell and B-cell proliferation.

C. Option C (Leukemia): As explained above, the Ochsner-Sherren regimen is primarily used in the treatment of acute lymphoblastic leukemia (ALL), not leukemia in general. Leukemia refers to the proliferation of abnormal white blood cells and can include ALL, chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML).

D. Option D (Myelodysplastic Syndrome): The Ochsner-Sherren regimen is not specifically used for myelodysplastic syndrome (MDS). MDS is a type of myeloproliferative disorder affecting the bone marrow and blood cell production, while the regimen targets ALL.

**Clinical Pearls and Tips:**

- When prescribing chemotherapy regimens, it is essential to understand the specific disease being targeted to ensure appropriate drug selection and dosage.
- Chemotherapy regimens often involve multiple drugs working together to maximize efficacy and minimize resistance development.
- Knowledge of different types of leukemia, their pathophysiology, and treatment options is crucial for accurate patient management and prognosis.